Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek A Wainwright

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
Immunotherapy (Los Angeles, Calif.)|November 8, 2016
The Kynurenine/Tryptophan Ratio and Glioblastoma Patients Treated with Hsppc-96 VaccineAlicia Lenzen, Lijie Zhai, Kristen L Lauing, et al.
Translational Cancer Research|October 5, 2018
Lessons learned from rindopepimut treatment in patients with EGFRvIII-expressing glioblastomaDavid C Binder, Erik Ladomersky, Alicia Lenzen, et al.
Brain, Behavior, and Immunity|March 20, 2012
CD4+ T cell-mediated neuroprotection is independent of T cell-derived BDNF in a mouse facial nerve axotomy modelJunping Xin, Nichole A Mesnard, Taylor Beahrs, et al.
Communications Biology|July 23, 2021
Tumor-derived NKG2D ligand sMIC reprograms NK cells to an inflammatory phenotype through CBM signalosome activationPayal Dhar, Fahmin Basher, Zhe Ji, et al.
Clinical & Experimental Neuroimmunology|April 10, 2024
Anti-aquaporin-4 immunoglobulin G/anti-myelin oligodendrocyte glycoprotein immunoglobulin G double-positive paraneoplastic neurological syndrome in a patient with triple-negative breast cancerAmna Siddiqui, Dylan Ross, Ronak H Jani, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 1, 2010
Bone marrow mesenchymal stem cells loaded with an oncolytic adenovirus suppress the anti-adenoviral immune response in the cotton rat modelAtique U Ahmed, Cleo E Rolle, Matthew A Tyler, et al.
Biomaterials|November 12, 2013
Fibrin-binding, peptide amphiphile micelles for targeting glioblastomaEun Ji Chung, Yu Cheng, Ramin Morshed, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 31, 2012
IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survivalDerek A Wainwright, Irina V Balyasnikova, Alan L Chang, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|May 19, 2025
Predicting medical prognosis in patients with glioblastoma during inpatient rehabilitation using bed mobility functionTomasz Gruchala, Christopher W Lewis, Kathryn Abplanalp, et al.
Cancer Immunology Research|April 12, 2022
Circadian Regulator CLOCK Drives Immunosuppression in GlioblastomaWenjing Xuan, Wen-Hao Hsu, Fatima Khan, et al.
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Immunotherapy (Los Angeles, Calif.)|November 8, 2016
The Kynurenine/Tryptophan Ratio and Glioblastoma Patients Treated with Hsppc-96 VaccineAlicia Lenzen, Lijie Zhai, Kristen L Lauing, et al.
Translational Cancer Research|October 5, 2018
Lessons learned from rindopepimut treatment in patients with EGFRvIII-expressing glioblastomaDavid C Binder, Erik Ladomersky, Alicia Lenzen, et al.
Brain, Behavior, and Immunity|March 20, 2012
CD4+ T cell-mediated neuroprotection is independent of T cell-derived BDNF in a mouse facial nerve axotomy modelJunping Xin, Nichole A Mesnard, Taylor Beahrs, et al.
Communications Biology|July 23, 2021
Tumor-derived NKG2D ligand sMIC reprograms NK cells to an inflammatory phenotype through CBM signalosome activationPayal Dhar, Fahmin Basher, Zhe Ji, et al.
Clinical & Experimental Neuroimmunology|April 10, 2024
Anti-aquaporin-4 immunoglobulin G/anti-myelin oligodendrocyte glycoprotein immunoglobulin G double-positive paraneoplastic neurological syndrome in a patient with triple-negative breast cancerAmna Siddiqui, Dylan Ross, Ronak H Jani, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 1, 2010
Bone marrow mesenchymal stem cells loaded with an oncolytic adenovirus suppress the anti-adenoviral immune response in the cotton rat modelAtique U Ahmed, Cleo E Rolle, Matthew A Tyler, et al.
Biomaterials|November 12, 2013
Fibrin-binding, peptide amphiphile micelles for targeting glioblastomaEun Ji Chung, Yu Cheng, Ramin Morshed, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 31, 2012
IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survivalDerek A Wainwright, Irina V Balyasnikova, Alan L Chang, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|May 19, 2025
Predicting medical prognosis in patients with glioblastoma during inpatient rehabilitation using bed mobility functionTomasz Gruchala, Christopher W Lewis, Kathryn Abplanalp, et al.
Cancer Immunology Research|April 12, 2022
Circadian Regulator CLOCK Drives Immunosuppression in GlioblastomaWenjing Xuan, Wen-Hao Hsu, Fatima Khan, et al.
Pageof 9